Compile Data Set for Download or QSAR
Report error Found 349 Enz. Inhib. hit(s) with all data for entry = 2041
TargetMitogen-activated protein kinase 3(Human)
Celgene Car

US Patent
LigandChemical structure of BindingDB Monomer ID 351022BDBM351022(US9796700, Compound I-112)
Affinity DataIC50: 100nMAssay Description:The protocol below describes continuous-read kinase assays to measure potency of compounds against activated ERK1 enzyme. The mechanics of the assay ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/23/2019
Entry Details
US Patent

TargetMitogen-activated protein kinase 3(Human)
Celgene Car

US Patent
LigandChemical structure of BindingDB Monomer ID 351028BDBM351028(US9796700, Compound I-118)
Affinity DataIC50: 100nMAssay Description:The protocol below describes continuous-read kinase assays to measure potency of compounds against activated ERK1 enzyme. The mechanics of the assay ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/23/2019
Entry Details
US Patent

TargetMitogen-activated protein kinase 3(Human)
Celgene Car

US Patent
LigandChemical structure of BindingDB Monomer ID 351025BDBM351025(US9796700, Compound I-128 | US9796700, Compound I-...)
Affinity DataIC50: 100nMAssay Description:The protocol below describes continuous-read kinase assays to measure potency of compounds against activated ERK1 enzyme. The mechanics of the assay ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/23/2019
Entry Details
US Patent

TargetMitogen-activated protein kinase 3(Human)
Celgene Car

US Patent
LigandChemical structure of BindingDB Monomer ID 351013BDBM351013(US9796700, Compound I-103)
Affinity DataIC50: 100nMAssay Description:The protocol below describes continuous-read kinase assays to measure potency of compounds against activated ERK1 enzyme. The mechanics of the assay ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/23/2019
Entry Details
US Patent

TargetMitogen-activated protein kinase 3(Human)
Celgene Car

US Patent
LigandChemical structure of BindingDB Monomer ID 50094304BDBM50094304(CHEMBL3590118 | US9796700, Compound I-108)
Affinity DataIC50: 100nMAssay Description:The protocol below describes continuous-read kinase assays to measure potency of compounds against activated ERK1 enzyme. The mechanics of the assay ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/23/2019
Entry Details
US Patent

TargetMitogen-activated protein kinase 3(Human)
Celgene Car

US Patent
LigandChemical structure of BindingDB Monomer ID 351044BDBM351044(US9796700, Compound I-311)
Affinity DataIC50: 100nMAssay Description:The protocol below describes continuous-read kinase assays to measure potency of compounds against activated ERK1 enzyme. The mechanics of the assay ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/23/2019
Entry Details
US Patent

TargetMitogen-activated protein kinase 3(Human)
Celgene Car

US Patent
LigandChemical structure of BindingDB Monomer ID 351041BDBM351041(US9796700, Compound I-131)
Affinity DataIC50: 100nMAssay Description:The protocol below describes continuous-read kinase assays to measure potency of compounds against activated ERK1 enzyme. The mechanics of the assay ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/23/2019
Entry Details
US Patent

TargetMitogen-activated protein kinase 3(Human)
Celgene Car

US Patent
LigandChemical structure of BindingDB Monomer ID 351031BDBM351031(US9796700, Compound I-121)
Affinity DataIC50: 100nMAssay Description:The protocol below describes continuous-read kinase assays to measure potency of compounds against activated ERK1 enzyme. The mechanics of the assay ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/23/2019
Entry Details
US Patent

TargetMitogen-activated protein kinase 3(Human)
Celgene Car

US Patent
LigandChemical structure of BindingDB Monomer ID 351032BDBM351032(US9796700, Compound I-122)
Affinity DataIC50: 100nMAssay Description:The protocol below describes continuous-read kinase assays to measure potency of compounds against activated ERK1 enzyme. The mechanics of the assay ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/23/2019
Entry Details
US Patent

TargetMitogen-activated protein kinase 3(Human)
Celgene Car

US Patent
LigandChemical structure of BindingDB Monomer ID 351029BDBM351029(US9796700, Compound I-119)
Affinity DataIC50: 100nMAssay Description:The protocol below describes continuous-read kinase assays to measure potency of compounds against activated ERK1 enzyme. The mechanics of the assay ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/23/2019
Entry Details
US Patent

TargetMitogen-activated protein kinase 3(Human)
Celgene Car

US Patent
LigandChemical structure of BindingDB Monomer ID 351030BDBM351030(US9796700, Compound I-120)
Affinity DataIC50: 100nMAssay Description:The protocol below describes continuous-read kinase assays to measure potency of compounds against activated ERK1 enzyme. The mechanics of the assay ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/23/2019
Entry Details
US Patent

TargetMitogen-activated protein kinase 3(Human)
Celgene Car

US Patent
LigandChemical structure of BindingDB Monomer ID 351035BDBM351035(US9796700, Compound I-125)
Affinity DataIC50: 100nMAssay Description:The protocol below describes continuous-read kinase assays to measure potency of compounds against activated ERK1 enzyme. The mechanics of the assay ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/23/2019
Entry Details
US Patent

TargetMitogen-activated protein kinase 3(Human)
Celgene Car

US Patent
LigandChemical structure of BindingDB Monomer ID 351033BDBM351033(US9796700, Compound I-123)
Affinity DataIC50: 100nMAssay Description:The protocol below describes continuous-read kinase assays to measure potency of compounds against activated ERK1 enzyme. The mechanics of the assay ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/23/2019
Entry Details
US Patent

TargetMitogen-activated protein kinase 3(Human)
Celgene Car

US Patent
LigandChemical structure of BindingDB Monomer ID 351034BDBM351034(US9796700, Compound I-124)
Affinity DataIC50: 100nMAssay Description:The protocol below describes continuous-read kinase assays to measure potency of compounds against activated ERK1 enzyme. The mechanics of the assay ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/23/2019
Entry Details
US Patent

TargetMitogen-activated protein kinase 3(Human)
Celgene Car

US Patent
LigandChemical structure of BindingDB Monomer ID 351047BDBM351047(US9796700, Compound I-136)
Affinity DataIC50: 100nMAssay Description:The protocol below describes continuous-read kinase assays to measure potency of compounds against activated ERK1 enzyme. The mechanics of the assay ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/23/2019
Entry Details
US Patent

TargetMitogen-activated protein kinase 3(Human)
Celgene Car

US Patent
LigandChemical structure of BindingDB Monomer ID 351048BDBM351048(US9796700, Compound I-137)
Affinity DataIC50: 100nMAssay Description:The protocol below describes continuous-read kinase assays to measure potency of compounds against activated ERK1 enzyme. The mechanics of the assay ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/23/2019
Entry Details
US Patent

TargetMitogen-activated protein kinase 3(Human)
Celgene Car

US Patent
LigandChemical structure of BindingDB Monomer ID 351045BDBM351045(US9796700, Compound I-134)
Affinity DataIC50: 100nMAssay Description:The protocol below describes continuous-read kinase assays to measure potency of compounds against activated ERK1 enzyme. The mechanics of the assay ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/23/2019
Entry Details
US Patent

TargetMitogen-activated protein kinase 3(Human)
Celgene Car

US Patent
LigandChemical structure of BindingDB Monomer ID 351051BDBM351051(US9796700, Compound I-140)
Affinity DataIC50: 100nMAssay Description:The protocol below describes continuous-read kinase assays to measure potency of compounds against activated ERK1 enzyme. The mechanics of the assay ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/23/2019
Entry Details
US Patent

TargetMitogen-activated protein kinase 3(Human)
Celgene Car

US Patent
LigandChemical structure of BindingDB Monomer ID 351050BDBM351050(US9796700, Compound I-139)
Affinity DataIC50: 100nMAssay Description:The protocol below describes continuous-read kinase assays to measure potency of compounds against activated ERK1 enzyme. The mechanics of the assay ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/23/2019
Entry Details
US Patent

TargetMitogen-activated protein kinase 3(Human)
Celgene Car

US Patent
LigandChemical structure of BindingDB Monomer ID 351096BDBM351096(US9796700, Compound I-191)
Affinity DataIC50: 100nMAssay Description:The protocol below describes continuous-read kinase assays to measure potency of compounds against activated ERK1 enzyme. The mechanics of the assay ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/23/2019
Entry Details
US Patent

TargetMitogen-activated protein kinase 3(Human)
Celgene Car

US Patent
LigandChemical structure of BindingDB Monomer ID 351097BDBM351097(US9796700, Compound I-192)
Affinity DataIC50: 100nMAssay Description:The protocol below describes continuous-read kinase assays to measure potency of compounds against activated ERK1 enzyme. The mechanics of the assay ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/23/2019
Entry Details
US Patent

TargetMitogen-activated protein kinase 3(Human)
Celgene Car

US Patent
LigandChemical structure of BindingDB Monomer ID 351098BDBM351098(US9796700, Compound I-193)
Affinity DataIC50: 100nMAssay Description:The protocol below describes continuous-read kinase assays to measure potency of compounds against activated ERK1 enzyme. The mechanics of the assay ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/23/2019
Entry Details
US Patent

TargetMitogen-activated protein kinase 3(Human)
Celgene Car

US Patent
LigandChemical structure of BindingDB Monomer ID 351119BDBM351119(US9796700, Compound I-214)
Affinity DataIC50: 100nMAssay Description:The protocol below describes continuous-read kinase assays to measure potency of compounds against activated ERK1 enzyme. The mechanics of the assay ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/23/2019
Entry Details
US Patent

TargetMitogen-activated protein kinase 3(Human)
Celgene Car

US Patent
LigandChemical structure of BindingDB Monomer ID 351117BDBM351117(US9796700, Compound I-212)
Affinity DataIC50: 100nMAssay Description:The protocol below describes continuous-read kinase assays to measure potency of compounds against activated ERK1 enzyme. The mechanics of the assay ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/23/2019
Entry Details
US Patent

TargetMitogen-activated protein kinase 3(Human)
Celgene Car

US Patent
LigandChemical structure of BindingDB Monomer ID 351111BDBM351111(US9796700, Compound I-206)
Affinity DataIC50: 100nMAssay Description:The protocol below describes continuous-read kinase assays to measure potency of compounds against activated ERK1 enzyme. The mechanics of the assay ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/23/2019
Entry Details
US Patent

TargetMitogen-activated protein kinase 3(Human)
Celgene Car

US Patent
LigandChemical structure of BindingDB Monomer ID 351110BDBM351110(US9796700, Compound I-205)
Affinity DataIC50: 100nMAssay Description:The protocol below describes continuous-read kinase assays to measure potency of compounds against activated ERK1 enzyme. The mechanics of the assay ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/23/2019
Entry Details
US Patent

TargetMitogen-activated protein kinase 3(Human)
Celgene Car

US Patent
LigandChemical structure of BindingDB Monomer ID 351116BDBM351116(US9796700, Compound I-211)
Affinity DataIC50: 100nMAssay Description:The protocol below describes continuous-read kinase assays to measure potency of compounds against activated ERK1 enzyme. The mechanics of the assay ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/23/2019
Entry Details
US Patent

TargetMitogen-activated protein kinase 3(Human)
Celgene Car

US Patent
LigandChemical structure of BindingDB Monomer ID 351113BDBM351113(US9796700, Compound I-208)
Affinity DataIC50: 100nMAssay Description:The protocol below describes continuous-read kinase assays to measure potency of compounds against activated ERK1 enzyme. The mechanics of the assay ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/23/2019
Entry Details
US Patent

TargetMitogen-activated protein kinase 3(Human)
Celgene Car

US Patent
LigandChemical structure of BindingDB Monomer ID 351133BDBM351133(US9796700, Compound I-228)
Affinity DataIC50: 100nMAssay Description:The protocol below describes continuous-read kinase assays to measure potency of compounds against activated ERK1 enzyme. The mechanics of the assay ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/23/2019
Entry Details
US Patent

TargetMitogen-activated protein kinase 3(Human)
Celgene Car

US Patent
LigandChemical structure of BindingDB Monomer ID 351134BDBM351134(US9796700, Compound I-229)
Affinity DataIC50: 100nMAssay Description:The protocol below describes continuous-read kinase assays to measure potency of compounds against activated ERK1 enzyme. The mechanics of the assay ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/23/2019
Entry Details
US Patent

TargetMitogen-activated protein kinase 3(Human)
Celgene Car

US Patent
LigandChemical structure of BindingDB Monomer ID 351126BDBM351126(US9796700, Compound I-221)
Affinity DataIC50: 100nMAssay Description:The protocol below describes continuous-read kinase assays to measure potency of compounds against activated ERK1 enzyme. The mechanics of the assay ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/23/2019
Entry Details
US Patent

TargetMitogen-activated protein kinase 3(Human)
Celgene Car

US Patent
LigandChemical structure of BindingDB Monomer ID 351153BDBM351153(US9796700, Compound I-248)
Affinity DataIC50: 100nMAssay Description:The protocol below describes continuous-read kinase assays to measure potency of compounds against activated ERK1 enzyme. The mechanics of the assay ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/23/2019
Entry Details
US Patent

TargetMitogen-activated protein kinase 3(Human)
Celgene Car

US Patent
LigandChemical structure of BindingDB Monomer ID 351142BDBM351142(US9796700, Compound I-237)
Affinity DataIC50: 100nMAssay Description:The protocol below describes continuous-read kinase assays to measure potency of compounds against activated ERK1 enzyme. The mechanics of the assay ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/23/2019
Entry Details
US Patent

TargetMitogen-activated protein kinase 3(Human)
Celgene Car

US Patent
LigandChemical structure of BindingDB Monomer ID 351147BDBM351147(US9796700, Compound I-242)
Affinity DataIC50: 100nMAssay Description:The protocol below describes continuous-read kinase assays to measure potency of compounds against activated ERK1 enzyme. The mechanics of the assay ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/23/2019
Entry Details
US Patent

TargetMitogen-activated protein kinase 3(Human)
Celgene Car

US Patent
LigandChemical structure of BindingDB Monomer ID 351148BDBM351148(US9796700, Compound I-243)
Affinity DataIC50: 100nMAssay Description:The protocol below describes continuous-read kinase assays to measure potency of compounds against activated ERK1 enzyme. The mechanics of the assay ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/23/2019
Entry Details
US Patent

TargetMitogen-activated protein kinase 3(Human)
Celgene Car

US Patent
LigandChemical structure of BindingDB Monomer ID 351145BDBM351145(US9796700, Compound I-240)
Affinity DataIC50: 100nMAssay Description:The protocol below describes continuous-read kinase assays to measure potency of compounds against activated ERK1 enzyme. The mechanics of the assay ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/23/2019
Entry Details
US Patent

TargetMitogen-activated protein kinase 3(Human)
Celgene Car

US Patent
LigandChemical structure of BindingDB Monomer ID 351146BDBM351146(US9796700, Compound I-241)
Affinity DataIC50: 100nMAssay Description:The protocol below describes continuous-read kinase assays to measure potency of compounds against activated ERK1 enzyme. The mechanics of the assay ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/23/2019
Entry Details
US Patent

TargetMitogen-activated protein kinase 3(Human)
Celgene Car

US Patent
LigandChemical structure of BindingDB Monomer ID 350908BDBM350908(US9796700, Compound I-2)
Affinity DataIC50: 100nMAssay Description:The protocol below describes continuous-read kinase assays to measure potency of compounds against activated ERK1 enzyme. The mechanics of the assay ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/23/2019
Entry Details
US Patent

TargetMitogen-activated protein kinase 3(Human)
Celgene Car

US Patent
LigandChemical structure of BindingDB Monomer ID 350913BDBM350913(US9796700, Compound I-7)
Affinity DataIC50: 100nMAssay Description:The protocol below describes continuous-read kinase assays to measure potency of compounds against activated ERK1 enzyme. The mechanics of the assay ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/23/2019
Entry Details
US Patent

TargetMitogen-activated protein kinase 3(Human)
Celgene Car

US Patent
LigandChemical structure of BindingDB Monomer ID 350911BDBM350911(US9796700, Compound I-5)
Affinity DataIC50: 100nMAssay Description:The protocol below describes continuous-read kinase assays to measure potency of compounds against activated ERK1 enzyme. The mechanics of the assay ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/23/2019
Entry Details
US Patent

TargetMitogen-activated protein kinase 3(Human)
Celgene Car

US Patent
LigandChemical structure of BindingDB Monomer ID 351157BDBM351157(US9796700, Compound I-258)
Affinity DataIC50: 100nMAssay Description:The protocol below describes continuous-read kinase assays to measure potency of compounds against activated ERK1 enzyme. The mechanics of the assay ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/23/2019
Entry Details
US Patent

TargetMitogen-activated protein kinase 3(Human)
Celgene Car

US Patent
LigandChemical structure of BindingDB Monomer ID 350925BDBM350925(US9796700, Compound I-19)
Affinity DataIC50: 100nMAssay Description:The protocol below describes continuous-read kinase assays to measure potency of compounds against activated ERK1 enzyme. The mechanics of the assay ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/23/2019
Entry Details
US Patent

TargetMitogen-activated protein kinase 3(Human)
Celgene Car

US Patent
LigandChemical structure of BindingDB Monomer ID 350927BDBM350927(US9796700, Compound I-20)
Affinity DataIC50: 100nMAssay Description:The protocol below describes continuous-read kinase assays to measure potency of compounds against activated ERK1 enzyme. The mechanics of the assay ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/23/2019
Entry Details
US Patent

TargetMitogen-activated protein kinase 3(Human)
Celgene Car

US Patent
LigandChemical structure of BindingDB Monomer ID 350923BDBM350923(US9796700, Compound I-17)
Affinity DataIC50: 100nMAssay Description:The protocol below describes continuous-read kinase assays to measure potency of compounds against activated ERK1 enzyme. The mechanics of the assay ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/23/2019
Entry Details
US Patent

TargetMitogen-activated protein kinase 3(Human)
Celgene Car

US Patent
LigandChemical structure of BindingDB Monomer ID 350924BDBM350924(US9796700, Compound I-18)
Affinity DataIC50: 100nMAssay Description:The protocol below describes continuous-read kinase assays to measure potency of compounds against activated ERK1 enzyme. The mechanics of the assay ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/23/2019
Entry Details
US Patent

TargetMitogen-activated protein kinase 3(Human)
Celgene Car

US Patent
LigandChemical structure of BindingDB Monomer ID 351186BDBM351186(US9796700, Compound I-283)
Affinity DataIC50: 100nMAssay Description:The protocol below describes continuous-read kinase assays to measure potency of compounds against activated ERK1 enzyme. The mechanics of the assay ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/23/2019
Entry Details
US Patent

TargetMitogen-activated protein kinase 3(Human)
Celgene Car

US Patent
LigandChemical structure of BindingDB Monomer ID 351187BDBM351187(US9796700, Compound I-284)
Affinity DataIC50: 100nMAssay Description:The protocol below describes continuous-read kinase assays to measure potency of compounds against activated ERK1 enzyme. The mechanics of the assay ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/23/2019
Entry Details
US Patent

TargetMitogen-activated protein kinase 3(Human)
Celgene Car

US Patent
LigandChemical structure of BindingDB Monomer ID 351184BDBM351184(US9796700, Compound I-281)
Affinity DataIC50: 100nMAssay Description:The protocol below describes continuous-read kinase assays to measure potency of compounds against activated ERK1 enzyme. The mechanics of the assay ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/23/2019
Entry Details
US Patent

TargetMitogen-activated protein kinase 3(Human)
Celgene Car

US Patent
LigandChemical structure of BindingDB Monomer ID 350929BDBM350929(US9796700, Compound I-307)
Affinity DataIC50: 100nMAssay Description:The protocol below describes continuous-read kinase assays to measure potency of compounds against activated ERK1 enzyme. The mechanics of the assay ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/23/2019
Entry Details
US Patent

TargetMitogen-activated protein kinase 3(Human)
Celgene Car

US Patent
LigandChemical structure of BindingDB Monomer ID 350915BDBM350915(US9796700, Compound I-9)
Affinity DataIC50: 100nMAssay Description:The protocol below describes continuous-read kinase assays to measure potency of compounds against activated ERK1 enzyme. The mechanics of the assay ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/23/2019
Entry Details
US Patent

Displayed 1 to 50 (of 349 total ) | Next | Last >>
Jump to: